Taylor, Cottrill, Erickson & Associates, Inc. Lemaitre Vascular Inc Transaction History
Taylor, Cottrill, Erickson & Associates, Inc.
- $359 Million
- Q3 2024
A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 3,270 shares of LMAT stock, worth $338,248. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,270
Previous 3,264
0.18%
Holding current value
$338,248
Previous $268,000
13.06%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding LMAT
# of Institutions
291Shares Held
20.5MCall Options Held
5.2KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$360 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.98MShares$205 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$163 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.16MShares$120 Million1.93% of portfolio
-
Geneva Capital Management LLC878KShares$90.8 Million1.39% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.27B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...